Subscribe to RSS
DOI: 10.5935/2526-8732.20200002
COVID-19 among cancer patients. What we know so far?
COVID-19 entre pacientes com câncer. O que sabemos até agora?
Financial support: none to declare.
ABSTRACT
In December 2019, a novel coronavirus disease (COVID-19) emerged in Wuhan, a city in the Hubei, Province of China. It rapidly spread in an epidemic fashion throughout China, followed by rapid increasing number of cases in many countries throughout the world, including Brazil. It is expected that oncologic patients have an increased risk of COVID-19 infection with possible worse clinical outcomes. We aim at reviewing current evidence of COVID-19 disease among cancer patients.
ABSTRACT
Em dezembro de 2019, uma nova doença de coronavírus (COVID-19) surgiu em Wuhan, uma cidade na província de Hubei, na China. Esta se espalhou rapidamente de maneira epidêmica por toda a China, seguida por um número crescente de casos em muitos países do mundo, inclusive no Brasil. Espera-se que pacientes oncológicos tenham um risco aumentado de infecção por COVID-19, com possíveis piores resultados clínicos. Nosso objetivo é revisar as evidências atuais da doença de COVID-19 entre pacientes com câncer.
Publication History
Received: 18 March 2020
Accepted: 20 March 2020
Article published online:
13 April 2020
© 2022. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
Renata D'Alpino Peixoto, Moises de Sousa Martins Lopes. COVID-19 among cancer patients. What we know so far?. Brazilian Journal of Oncology 2020; 16: e-20200002.
DOI: 10.5935/2526-8732.20200002
-
REFERENCES
- World Health Organization (WHO). Director-General's remarks at the media briefing on 2019nCoV [Internet]. Genebra: WHO;; 2020. Feb access in 2020 Feb 12 https://www.who.int/dg/speeches/detail/who-director-general-smarks-at-the-media-briefing-on-2019-ncov-on11-february-2020
- Gudiol C, Aguado JM, Carratalà J.. Bloodstream infections in patients with solid tumors. Virulence 2016; Apr; 7 (03) 298-308
-
Novel Coronavirus Pneumonia Emergency Response Epidemiology Team.
Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020. China CDC Weekly [Internet]. 2020; [access in 2020 Feb 12]. Available from: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51
-
Wu Z,
McGoogan JM.
Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. . JAMA. 2020. Feb; 24;. Epub ahead of print https://doi.org/10.1001/jama.2020.2648
-
Guan WJ,
Ni ZY,
Hu Y,
Liang WH,
Ou CQ,
He JX.
et al
Clinical characteristics of coronavirus disease 2019 in China. . N Engl J Med. 2020. Feb; 28;. Epub ahead of print. https://doi.org/10.1056/NEJMoa2002032
- Liang W, Guan W, Chen R, Wang W, Li J, Xu K. et al Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; Mar; 21 (03) 335-337 https://doi.org/10.1016/S1470-2045(20)30096-6